Common diabetes drug enters fight against rare childhood brain cancer
NCT ID NCT07226453
Summary
This study is testing whether metformin, a medication typically used for diabetes, can help control recurrent PFA ependymoma, a rare brain tumor that affects children and young adults. Researchers will give participants daily oral metformin to see if it stabilizes tumor growth and changes certain markers in tumor cells. The study involves 30 participants aged 1-39 who have already had surgery and radiation for their tumor but have seen it return or progress.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTERIOR FOSSA EPENDYMAL TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.